Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Jan 15, 2014 (Vol. 34, No. 2)

Bioinformatics Organization

URL:www.bioinformatics.org
  • Diverse resources for beginners and experts
  • None

Whether you are a researcher who regularly relies upon bioinformatics, or you have no idea what “bioinformatics” is, the website of the authoritative-sounding Bioinformatics Organization will surely be a great resource for you. For the neophytes out there, the wiki page on the site provides a general introduction to, and answers general questions about, the field of bioinformatics. The pros, meanwhile, can take advantage of online analysis tools developed by the group such as PrimerX, a program to automate the design of mutagenic PCR primers. Additionally, the site includes online databases, forums, and a vast array of software development projects. Anybody can become a basic member of the organization for free (and at more than 34,000 members, the group seems to be doing something right).

  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »